Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036267 · ClinicalTrials.gov registry record · NA
Feasibility of the BREATHE Asthma Intervention Trial
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03036267 is a NA study that has completed, run by Columbia University. The registered enrollment target is 46 participants.
The verdict
NCT03036267, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Asthma rates are high and asthma control is greatly reduced in Black, Medicaid-insured adults, due in part to their poor adherence to inhaled corticosteroids (ICS), which in turn may be due to erroneous health beliefs about asthma and negative beliefs regarding ICS. A brief shared decision-making intervention for use by primary care providers in Federally Qualified Health Centers (FQHCs) has the potential to be a novel avenue to greatly improve asthma control in this high-risk patient group.
Interventions
- BEHAVIORAL BREATHE
- OTHER Attention Control Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2017-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03036267
The ClinicalTrials.gov registry entry for NCT03036267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BREATHE is the first listed.
NCT03036267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03036267 about?
NCT03036267 is a clinical study titled "Feasibility of the BREATHE Asthma Intervention Trial". Asthma rates are high and asthma control is greatly reduced in Black, Medicaid-insured adults, due in part to their poor adherence to inhaled corticosteroids (ICS), which in turn may be due to erroneous health beliefs about asthma and negative beliefs regarding ICS. A brief shared decision-making in...
What is the current status of trial NCT03036267?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2017-04-04. Estimated completion is 2017-09-22.
What interventions are being tested in trial NCT03036267?
The interventions under investigation include: BREATHE (BEHAVIORAL), Attention Control Condition (OTHER).
Who is sponsoring clinical trial NCT03036267?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.